Reuters Health News Summary

Following is a summary of current health news briefs. Bill Gates urges Afghanistan and Pakistan to 'get to zero' in polio fight

Local Afghan Taliban leaders are hindering global efforts to end polio, but Afghanistan and Pakistan must continue their fight to "get to zero" cases, the philanthropist Bill Gates said on Monday. In a telephone interview with Reuters, Gates was optimistic about the global plan to eradicate the paralyzing viral disease, but said Afghanistan's conflict and power struggles hamper progress. Bayer, J&J settle U.S. Xarelto litigation for $775 million

Bayer AG and Johnson & Johnson have agreed to settle more than 25,000 U.S. lawsuits over their blockbuster blood thinner Xarelto for a total of $775 million, court documents on Monday showed. The amount will be shared equally between the two companies that jointly developed the drug. Bayer and J&J do not admit liability under the agreement. Women diagnosed years later than men for same diseases

(Reuters Health) - For a wide range of diseases, diagnosis comes later in life for women than for men, according to a large Danish study. Researchers don't know whether the later diagnoses are due to genetics, the environment, possible biases in the healthcare system - or some combination of reasons. Early test of male birth control pill shows no safety problems

(Reuters Health) - After taking an experimental male birth control pill for 28 days, 30 men reported no serious side effects and the drug showed signs of decreasing sperm production, according to results of a phase 1 safety test reported Sunday in a poster session at ENDO 2019, the Endocrine Society's annual meeting in New Orleans. The purpose of phase I trials is to gather initial data on a drug's safety, not to test whether it's effective. In fact, the duration of the trial was insufficient to prove the pill's effectiveness as a contraceptive. That would take 60 to 90 days of use, the researchers said. Instead, the hormone changes seen in the volunteers were "consistent with effective contraception," according to a news release. Tiniest U.S. preemies more likely to end up in lower-quality NICU if they're black

(Reuters Health) - In a large national study that included nearly 90 percent of all preterm and low-birth-weight babies born in the U.S. in a recent three-year period, researchers found that black infants were more likely than white infants to receive care in a lower-scoring neonatal intensive care unit (NICU). The hospital's quality of care is directly related to deaths and complications in newborns, said study coauthor Erika Edwards of the University of Vermont. Complications commonly seen in premature babies can have lifelong consequences. For example, she said, "Chronic lung disease is related to asthma which is already an issue in minority populations. And brain injury can cause developmental delays." Mozambique prepares for cholera after cyclone wreaks havoc

Rescue teams in Mozambique moved hundreds of people displaced by Cyclone Idai's massive and deadly flooding to safer shelters on Monday, while the government made preparations for a cholera outbreak that it says is inevitable amid the devastation. In areas west of the port city of Beira, hundreds of people were trapped for more than a week after Idai hit, surviving in vast tracts of submerged land with no access to clean water and shrinking food supplies. Oklahoma top court clears way for Purdue, J&J, Teva to face opioid trial

Oklahoma's top court on Monday declined to delay a landmark trial set for May in a multibillion-dollar lawsuit accusing OxyContin maker Purdue Pharma LP and two other drugmakers of helping fuel an opioid abuse and overdose epidemic in the state. The Oklahoma Supreme Court's decision was a win for the state's attorney general, whose case is set to be the first to face trial of roughly 2,000 lawsuits nationally seeking to hold opioid manufacturers responsible for contributing to the epidemic. Congo Ebola epidemic exceeds 1,000 cases: health ministry

Congo's Ebola epidemic has now exceeded 1,000 cases, the Health Ministry said on Monday, with a death toll of 629 in the world's second worst ever outbreak. Health workers have been better prepared than ever for this latest epidemic of the hemorrhagic fever, which causes severe vomiting, diarrhea and bleeding, and kills more than half those it infects. New technologies like a trial vaccine, experimental treatments and futuristic cube-shaped mobile units for treating patients have helped curb the spread of the virus. Springtime heralds moose collision season in New England

(Reuters Health) - Drivers in northern New England have long known to watch out for moose on the road, but a new study finds potentially fatal collisions with these large animals still happen on average more than once a day. Collisions with moose happen most often in the late spring and the summer, especially just after sunset and near sunrise. They are much more dangerous than collisions with other wildlife, Dr. David Clark of the Maine Medical Center in Portland and colleagues warn in the Journal of the American College of Surgeons. EU approves AstraZeneca's drug for adjunct use in Type-1 diabetes

British drugmaker AstraZeneca Plc said on Monday the European Commission approved its diabetes drug Forxiga for use as an oral supplement to insulin in adults with a rare type of the disease. Forxiga can now be used along with insulin in patients with Type-1 diabetes and a Body Mass Index (BMI) of 27 or more when insulin alone has not been able to control blood sugar levels, the company said. Type-1 diabetes is a chronic condition in which the pancreas produces little or no insulin hormone.